List of works - Won Kim

A crystal ball to forecast treatment responsiveness in nonalcoholic fatty liver disease

scientific article published in 2022

Additive effects of PNPLA3 and TM6SF2 on the histological severity of non-alcoholic fatty liver disease

scientific article published on 29 November 2017

Alcohol-Related Liver Disease Is Rarely Detected at Early Stages Compared With Liver Diseases of Other Etiologies Worldwide

scientific article published on 29 January 2019

Association between body size-metabolic phenotype and nonalcoholic steatohepatitis and significant fibrosis

scientific article published on 18 September 2019

Association between muscle strength and advanced fibrosis in non-alcoholic fatty liver disease: a Korean nationwide survey

scientific article published on 07 July 2020

Association of arterial stiffness with the histological severity of nonalcoholic fatty liver disease

scientific article published on 02 December 2020

Can hepatic steatosis really promote hepatitis B viral hepatocarcinogenesis? The jury is out on

scientific article published on 28 December 2018

Circulating lipidomic alterations in obese and non-obese subjects with non-alcoholic fatty liver disease

scientific article published on 06 September 2020

Comparison of the Reliability of Acoustic Radiation Force Impulse Imaging and Supersonic Shear Imaging in Measurement of Liver Stiffness

scientific article published on 06 July 2015

Concomitant food intake does not affect the efficacy of entecavir in chronic hepatitis B patients with virological response: a randomized, multicenter, noninferiority trial

scientific article published on 02 November 2018

Development of colorectal cancer predicts increased risk of subsequent hepatocellular carcinoma in patients with alcoholic liver disease: case-control and cohort study

article

Diagnostic and therapeutic strategies for severe alcoholic hepatitis

scientific article published on January 2015

Distinct signatures of gut microbiome and metabolites associated with significant fibrosis in non-obese NAFLD

scientific article published on 05 October 2020

Efficacy of granulocyte colony stimulating factor in patients with severe alcoholic hepatitis with partial or null response to steroid (GRACIAH trial): study protocol for a randomized controlled trial

Elevated Alanine Aminotransferase in Early Pregnancy and Subsequent Development of Gestational Diabetes and Preeclampsia

scientific article published on 06 July 2020

Expression patterns of STAT3, ERK and estrogen-receptor α are associated with development and histologic severity of hepatic steatosis: a retrospective study.

scientific article published on 3 April 2018

Growth differentiation factor 15 predicts advanced fibrosis in biopsy-proven non-alcoholic fatty liver disease.

scientific article

Incidence, inhospital mortality, and readmission among patients with alcoholic hepatitis in Korea: A nationwide study

article

Interaction effect between NAFLD severity and high carbohydrate diet on gut microbiome alteration and hepatic <i>de novo</i> lipogenesis

scientific article published on 01 January 2022

It's Ready for Targeting Muscle in Nonalcoholic Fatty Liver in This Era of Aging

scientific article published on 01 January 2019

Letter: the efficacy of oltipraz in patients with non-alcoholic fatty liver disease has not been confirmed-authors' reply.

scientific article published in July 2017

Long-Term Effect of PNPLA3 on the Aggravation of Nonalcoholic Fatty Liver Disease in the Biopsy-Proven Cohort

scientific article published in 2022

Muscle alterations are independently associated with significant fibrosis in patients with nonalcoholic fatty liver disease

scientific article published on 08 November 2020

Nonalcoholic fatty liver disease-based risk prediction of adverse pregnancy outcomes: Ready for prime time?

scientific article published in 2022

Nonalcoholic steatohepatitis is associated with a higher risk of advanced colorectal neoplasm

scientific article published on 26 June 2019

Overproduction of inter-α-trypsin inhibitor heavy chain 1 after loss of Gα13 in liver exacerbates systemic insulin resistance in mice

scientific article published on 01 October 2019

Point shear wave elastography predicts fibrosis severity and steatohepatitis in alcohol-related liver disease

scientific article published on 19 December 2019

Portal inflammation predicts renal dysfunction in patients with nonalcoholic fatty liver disease

scientific article published on 17 June 2020

Predictors of Nonalcoholic Steatohepatitis and Significant Fibrosis in Non-Obese Nonalcoholic Fatty Liver Disease

article

Prognostic Value of the Alcoholic Hepatitis Histologic Score in Korean Patients with Biopsy-Proven Alcoholic Hepatitis

scientific article published on 29 May 2020

Prognostic implications of trunk muscle mass in liver cirrhosis

scientific article published on 10 September 2018

Prospective comparison among transient elastography, supersonic shear imaging, and ARFI imaging for predicting fibrosis in nonalcoholic fatty liver disease

scientific article published on 27 November 2017

Pulmonary function is associated with fibrosis severity in patients with biopsy-proven nonalcoholic fatty liver disease

scientific article published on 01 August 2020

Pulmonary function is associated with fibrosis severity in patients with biopsy-proven nonalcoholic fatty liver disease

scientific article published on 20 November 2020

Randomised clinical trial: the efficacy and safety of oltipraz, a liver X receptor alpha-inhibitory dithiolethione in patients with non-alcoholic fatty liver disease.

scientific article

Reply to: Influence of Helicobacter pylori-connected metabolic syndrome on nonalcoholic fatty liver disease and its related colorectal neoplasm high risk

scientific article published on 13 November 2019

Steatosis severity affects the diagnostic performances of noninvasive fibrosis tests in nonalcoholic fatty liver disease

scientific article published on 10 August 2017

The Risk of Pregnancy-Associated Hypertension in Women with Nonalcoholic Fatty Liver Disease

scientific article published on 17 June 2020

Treatment Options in Non-alcoholic Fatty Liver Disease

scientific article

mTOR controls ChREBP transcriptional activity and pancreatic β cell survival under diabetic stress

scientific article published on 12 June 2017

List of works by Won Kim

A crystal ball to forecast treatment responsiveness in nonalcoholic fatty liver disease

Additive effects of PNPLA3 and TM6SF2 on the histological severity of non-alcoholic fatty liver disease

Alcohol-Related Liver Disease Is Rarely Detected at Early Stages Compared With Liver Diseases of Other Etiologies Worldwide

Association between body size-metabolic phenotype and nonalcoholic steatohepatitis and significant fibrosis

Association between muscle strength and advanced fibrosis in non-alcoholic fatty liver disease: a Korean nationwide survey

Association of arterial stiffness with the histological severity of nonalcoholic fatty liver disease

Can hepatic steatosis really promote hepatitis B viral hepatocarcinogenesis? The jury is out on

Circulating lipidomic alterations in obese and non-obese subjects with non-alcoholic fatty liver disease

Comparison of the Reliability of Acoustic Radiation Force Impulse Imaging and Supersonic Shear Imaging in Measurement of Liver Stiffness

Concomitant food intake does not affect the efficacy of entecavir in chronic hepatitis B patients with virological response: a randomized, multicenter, noninferiority trial

Development of colorectal cancer predicts increased risk of subsequent hepatocellular carcinoma in patients with alcoholic liver disease: case-control and cohort study

Diagnostic and therapeutic strategies for severe alcoholic hepatitis

Distinct signatures of gut microbiome and metabolites associated with significant fibrosis in non-obese NAFLD

Efficacy of granulocyte colony stimulating factor in patients with severe alcoholic hepatitis with partial or null response to steroid (GRACIAH trial): study protocol for a randomized controlled trial

Elevated Alanine Aminotransferase in Early Pregnancy and Subsequent Development of Gestational Diabetes and Preeclampsia

Expression patterns of STAT3, ERK and estrogen-receptor α are associated with development and histologic severity of hepatic steatosis: a retrospective study.

Growth differentiation factor 15 predicts advanced fibrosis in biopsy-proven non-alcoholic fatty liver disease.

Incidence, inhospital mortality, and readmission among patients with alcoholic hepatitis in Korea: A nationwide study

Interaction effect between NAFLD severity and high carbohydrate diet on gut microbiome alteration and hepatic <i>de novo</i> lipogenesis

It's Ready for Targeting Muscle in Nonalcoholic Fatty Liver in This Era of Aging

Letter: the efficacy of oltipraz in patients with non-alcoholic fatty liver disease has not been confirmed-authors' reply.

Long-Term Effect of PNPLA3 on the Aggravation of Nonalcoholic Fatty Liver Disease in the Biopsy-Proven Cohort

Muscle alterations are independently associated with significant fibrosis in patients with nonalcoholic fatty liver disease

Nonalcoholic fatty liver disease-based risk prediction of adverse pregnancy outcomes: Ready for prime time?

Nonalcoholic steatohepatitis is associated with a higher risk of advanced colorectal neoplasm

Overproduction of inter-α-trypsin inhibitor heavy chain 1 after loss of Gα13 in liver exacerbates systemic insulin resistance in mice

Point shear wave elastography predicts fibrosis severity and steatohepatitis in alcohol-related liver disease

Portal inflammation predicts renal dysfunction in patients with nonalcoholic fatty liver disease

Predictors of Nonalcoholic Steatohepatitis and Significant Fibrosis in Non-Obese Nonalcoholic Fatty Liver Disease

Prognostic Value of the Alcoholic Hepatitis Histologic Score in Korean Patients with Biopsy-Proven Alcoholic Hepatitis

Prognostic implications of trunk muscle mass in liver cirrhosis

Prospective comparison among transient elastography, supersonic shear imaging, and ARFI imaging for predicting fibrosis in nonalcoholic fatty liver disease

Pulmonary function is associated with fibrosis severity in patients with biopsy-proven nonalcoholic fatty liver disease

Pulmonary function is associated with fibrosis severity in patients with biopsy-proven nonalcoholic fatty liver disease

Randomised clinical trial: the efficacy and safety of oltipraz, a liver X receptor alpha-inhibitory dithiolethione in patients with non-alcoholic fatty liver disease.

Reply to: Influence of Helicobacter pylori-connected metabolic syndrome on nonalcoholic fatty liver disease and its related colorectal neoplasm high risk

Steatosis severity affects the diagnostic performances of noninvasive fibrosis tests in nonalcoholic fatty liver disease

The Risk of Pregnancy-Associated Hypertension in Women with Nonalcoholic Fatty Liver Disease

Treatment Options in Non-alcoholic Fatty Liver Disease

mTOR controls ChREBP transcriptional activity and pancreatic β cell survival under diabetic stress